Fig. 3From: SPIRE – combining SGI-110 with cisplatin and gemcitabine chemotherapy for solid malignancies including bladder cancer: study protocol for a phase Ib/randomised IIa open label clinical trialSPIRIT figure for SPIRE phase IIa dose expansion component (Additional file 4)Back to article page